Document is current
Any future updates will be listed below
-
Authors
Jendrusch, Michael A https://orcid.org/0000-0003-2385-6103
Yang, Alessio L J https://orcid.org/0000-0003-4981-872X
Cacace, Elisabetta
Bobonis, Jacob https://orcid.org/0000-0001-9293-9733
Voogdt, Carlos G P https://orcid.org/0000-0002-2552-0059
Kaspar, Sarah https://orcid.org/0009-0005-9745-6673
Schweimer, Kristian https://orcid.org/0000-0002-3837-8442
Perez-Borrajero, Cecilia https://orcid.org/0000-0002-3167-7159
Lapouge, Karine https://orcid.org/0000-0003-0620-9553
Scheurich, Jacob
Remans, Kim https://orcid.org/0000-0002-4394-7953
Hennig, Janosch https://orcid.org/0000-0001-5214-7002
Typas, Athanasios https://orcid.org/0000-0002-0797-9018
Korbel, Jan O https://orcid.org/0000-0002-2798-3794
Sadiq, S Kashif https://orcid.org/0000-0002-5112-0307
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (de.NBI project: 031A537B)
Volkswagen Foundation (contract 95826)
Volkswagen Foundation (93874-1)
EC | Horizon Europe | Excellent Science | HORIZON EUROPE Marie Sklodowska-Curie Actions (COFUND grant nr. 847543)
- License Information
-
More Information
Article History
Received: 8 April 2025
Revised: 5 May 2025
Accepted: 6 May 2025
First Online: 17 June 2025
Disclosure and competing interests statement
: SKS is the Founder and Chief Executive Officer of DenovAI Biotech Ltd. in which MJ, JOK and SKS have financial interests. MJ, JOK, and SKS are co-inventors on US Provisional Patent Application No. 63/329,522/PCT patent application (published as WO 2023/198726 A1 on 19.10.2023). JOK and AT are members of the Advisory Editorial Board of Molecular Systems Biology. This has no bearing on the editorial consideration of this article for publication.
